Business Overview of IBEX
IBEX Technologies Inc. is a publicly traded company listed on the TSX-Venture Exchange (IBT.V).
The Company operates principally through IBEX Pharmaceuticals Inc.
IBEX Pharmaceutical’s primary business is the manufacture and selling of high purity enzymes for in-vitro diagnostics and research. The Company also makes and sell osteoarthritis kits (ELISA’s) for pre-clinical research.
IBEX Pharmaceutical provides important services to major in-vitro companies some of which are acknowledged below:
- Seed Bank Creation
- Fermentation and Biotransformation
- Protein Purification
- Protein Formulation
- Filling of Device Components
- Lyophilization
- Seed Bank Creation
- Fermentation and Biotransformation
- Protein Purification
- Protein Formulation
- Filling of Device Components
- Lyophilization
The IBEX Pharmaceutical’s Quality Management System is certified ISO 13485:2016.